Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry

Nature Medicine

Volumn 12, Issue 8, 2006, Pages 972-977

  Chattopadhyay, Pratip K ^a   Price, David A ^a   Harper, Theresa F ^b   Betts, Michael R ^a,c   Yu, Joanne ^a   Gostick, Emma ^d   Perfetto, Stephen P ^a   Goepfert, Paul ^e   Koup, Richard A ^a   De Rosa, Stephen C ^f   Bruchez, Marcel P ^g   Roederer, Mario ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Solus Biosystems Inc   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; NANOCRYSTAL; QUANTUM DOT;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INNATE IMMUNITY; PRIORITY JOURNAL; SEMICONDUCTOR; T LYMPHOCYTE;

ANTIGENS, CD3; ANTIGENS, CD8; EPITOPES; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MAJOR HISTOCOMPATIBILITY COMPLEX; NANOTECHNOLOGY; QUANTUM DOTS; SEMICONDUCTORS; T-LYMPHOCYTES;

EID: 33746788900     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1371     Document Type: Article

References (29)

1. Perfetto, S.P., Chattopadhyay, P.K. & Roederer, M. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 4, 648-655 (2004).
2. Roederer, M. Compensation is not dependent on signal intensity or on number of parameters. Cytometry 46, 357-359 (2001).
3. Roederer, M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45, 194-205 (2001).
4. Bruchez, M., Jr., Moronne, M., Gin, P., Weiss, S. & Alivisatos, A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 281, 2013-2016 (1998).
5. Hotz, C.Z. Applications of quantum dots in biology: an overview. Methods Mol. Biol. 303, 1-17 (2005).
6. Michalet, X. et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538-544 (2005).
7. Lim, Y.T. et al. Selection of quantum dot wavelengths for biomedical assays and imaging. Mol. Imaging 2, 50-64 (2003).
8. Goldman, E.R., Mattoussi, H., Anderson, G.P., Medintz, I.L. & Mauro, J.M. Fluoroimmunoassays using antibody-conjugated quantum dots. Methods Mol. Biol. 303, 19-34 (2005).
9. Chan, W.C. & Nie, S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281, 2016-2018 (1998).
10. + T cells. Blood 101, 2711-2720 (2003).
11. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8, 379-385 (2002).
12. Chen, G. et al. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 98, 156-164 (2001).
13. Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410, 106-111 (2001).
14. Sallusto, F. et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
15. Chattopadhyay, P.K. & Roederer, M. Immunophenotyping of T cell subpopulations in HIV disease. in Current Protocols in Immunology, Vol. Unit 12.12 (2005).
16. De Rosa, S.C., Herzenberg, L.A. & Roederer, M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med. 7, 245-248 (2001).
17. + T cells. J. Exp. Med. 186, 1407-1418 (1997).
18. Amlot, P.L., Tahami, F., Chinn, D. & Rawlings, E. Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue. Clin. Exp. Immunol. 105, 176-182 (1996).
19. Plaeger-Marshall, S. et al. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children. J. Acquir. Immune Defic. Syndr. 6, 984-993 (1993).
20. Sing, G., Butterworth, L., Chen, X., Bryant, A. & Cooksley, G. Composition of peripheral blood lymphocyte populations during different stages of chronic infection with hepatitis B virus. J. Viral Hepat. 5, 83-93 (1998).
21. Rowland-Jones, S.L. et al. An antigen processing polymorphism revealed by HLA-B8-restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism. Eur. J. Immunol. 23, 1999-2004 (1993).
22. Price, D.A. et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94, 1890-1895 (1997).
23. Diamond, D.J., York, J., Sun, J.Y., Wright, C.L. & Forman, S.J. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90, 1751-1767 (1997).
24. Scotet, E. et al. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J. Exp. Med. 184, 1791-1800 (1996).
25. Hutchinson, S.L. et al. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities. J. Biol. Chem. 278, 24285-24293 (2003).
26. Ballou, B., Lagerholm, B.C., Ernst, L.A., Bruchez, M.P. & Waggoner, A.S. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15, 79-86 (2004).
27. Jaiswal, J.K., Mattoussi, H., Mauro, J.M. & Simon, S.M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21, 47-51 (2003).
28. Rieger, S., Kulkarni, R.P., Darcy, D., Fraser, S.E. & Koster, R.W. Quantum dots are powerful multipurpose vital labeling agents in zebrafish embryos. Dev. Dyn. 234, 670-681 (2005).
29. Perfetto, S.P., Ambrozak, D.R., Roederer, M. & Koup, R.A. Viable infectious cell sorting in a BSL-3 facility. Methods Mol. Biol. 263, 419-424 (2004).